Literature DB >> 8273390

Operative results in 143 patients with hepatocellular carcinoma.

T Segawa1, R Tsuchiya, J Furui, K Izawa, T Tsunoda, T Kanematsu.   

Abstract

A total of 143 patients who underwent hepatic resection for hepatocellular carcinoma in our department were reviewed. The review was conducted for two periods: 1970-1982 (early period) and 1983-1990 (late period), that is, the periods before and after introduction of the hepatic surgical technique involving the use of a microwave tissue coagulator and ultrasonic dissector. One patient underwent extended lobectomy, 12 lobectomy, 9 segmentectomy, and 26 partial hepatectomy during the early period. Two patients underwent extended lobectomy, 7 lobectomy, 9 segmentectomy, 36 subsegmentectomy, and 41 partial hepatectomy during the late period. Operative mortality and hospital mortality were 16.7% and 22.9% during the early period and 1.1% and 8.4% during the late period, respectively. The overall mortality rate was significantly lower during the late period than during the early period. Postoperative complications developed in 62.5% of the patients with hepatic resection during the early period and in 48.4% of the patients during the late period. The size of tumors during the early period was significantly greater than that during the late period. Intraoperative blood loss during the late period was significantly lower than that during the early period. The survival curve was better among patients who underwent hepatic resection during the late period than among those during the early period. The satisfactory results during the late period are due to the introduction of intraoperative ultrasonography, microwave tissue coagulation, and ultrasonic dissection for hepatic surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8273390     DOI: 10.1007/bf01659138

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience.

Authors:  E C Lai; I O Ng; K T You; S T Fan; F P Mok; E S Tan; J Wong
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

2.  Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy.

Authors:  K Mori; K Ozawa; Y Yamamoto; A Maki; Y Shimahara; N Kobayashi; Y Yamaoka; K Kumada
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

3.  Second hepatic resection for recurrent hepatocellular carcinoma.

Authors:  N Nagasue; H Yukaya; Y Ogawa; Y Sasaki; Y C Chang; K Niimi
Journal:  Br J Surg       Date:  1986-06       Impact factor: 6.939

Review 4.  The changing role of surgery in the treatment of primary liver cancer.

Authors:  Z Y Tang; Y Q Yu; X D Zhou
Journal:  Semin Surg Oncol       Date:  1986

5.  Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival.

Authors:  E Okamoto; N Tanaka; N Yamanaka; A Toyosaka
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

6.  Major liver resection: perioperative course and management.

Authors:  H Ekberg; K G Tranberg; R Andersson; B Jeppsson; S Bengmark
Journal:  Surgery       Date:  1986-07       Impact factor: 3.982

7.  Hepatic resection for hepatocellular carcinoma.

Authors:  T Tsuzuki; A Sugioka; M Ueda; S Iida; T Kanai; H Yoshii; K Nakayasu
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

8.  Surgery of small hepatocellular carcinoma. Analysis of 144 cases.

Authors:  Z Y Tang; Y Q Yu; X D Zhou; Z C Ma; R Yang; J Z Lu; Z Y Lin; B H Yang
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

9.  Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function.

Authors:  E Okamoto; A Kyo; N Yamanaka; N Tanaka; K Kuwata
Journal:  Surgery       Date:  1984-05       Impact factor: 3.982

10.  Clinical management of recurrent hepatocellular carcinoma after primary resection.

Authors:  T Kanematsu; T Matsumata; K Takenaka; Y Yoshida; H Higashi; K Sugimachi
Journal:  Br J Surg       Date:  1988-03       Impact factor: 6.939

View more
  6 in total

1.  Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines.

Authors:  Tae-Jin Song; David P Eisenberg; Prasad S Adusumilli; Michael Hezel; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

2.  Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas.

Authors:  Atsushi Sasaki; Yukio Iwashita; Kohei Shibata; Toshifumi Matsumoto; Masayuki Ohta; Seigo Kitano
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

3.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

4.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

5.  A multicentre controlled study of the InLine radiofrequency ablation device for liver transection.

Authors:  Peng Yao; Frank Chu; Steve Daniel; Aravin Gunasegaram; Tristan Yan; Werner Lindemann; Georg Pistorius; Martin Schilling; Junji Machi; Randall Zuckerman; David L Morris
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

6.  Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors.

Authors:  Seung Up Kim; Do Young Kim; Jun Yong Park; Sang Hoon Ahn; Hyung Joong Nah; Chae Yoon Chon; Kwang-Hyub Han
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-16       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.